Advertisement

European Journal of Pediatrics

, Volume 155, Issue 5, pp 422–423 | Cite as

Dextrometorphan in molybdenum cofactor deficiency

  • Gerhard Kurlemann
  • Ottfried Debus
  • Gerhard Schuierer
Letters To The Editors

Keywords

Public Health Molybdenum Molybdenum Cofactor Molybdenum Cofactor Deficiency 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Abbreviations

DM

dextromethorphan

MCD

molybdenum cofactor deficiency

NMDA

N-methyl-D-aspartate

References

  1. 1.
    Ferkany JW, Borosky SA, Clissold DB, Pontecorvo J (1988) Dextromethorphan inhibits NMDA-induced convulsion. Eur J Pharmacology 151: 151–154Google Scholar
  2. 2.
    Johnson JL, Wadman SK (1988) Molydenum cofactor deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease, 6th edn. McGraw-Hill, New York, pp 1463–1475Google Scholar
  3. 3.
    Olney JW, Misra CH, Gubareff T de (1975) Cysteine-S-sulfate: brain damaging metabolite in sulfite oxidase deficiency. J Neuropathol Exp Neurol 34: 167–177Google Scholar
  4. 4.
    Schmitt B, Steinmann B, Gitzelmann R, Thun-Hohenstein L, Mascher H, Dumermuth G (1993) Nonketotic hyperglycinemia: clinical and electrophysiologic effects of dextromethorphan, an antagonist of the NMDA receptor. Neurology 43: 421–424Google Scholar
  5. 5.
    Schuierer G, Kurlemann G, Bick U, Stephani U (1995) Molybdenum cofactor deficiency: CT and MR findings. Neuropediatrics 26: 51–54Google Scholar

Copyright information

© Springer-Verlag 1996

Authors and Affiliations

  • Gerhard Kurlemann
    • 1
  • Ottfried Debus
    • 1
  • Gerhard Schuierer
    • 2
  1. 1.Bereich NeuropädiatrieUniversitäts-Kinderklinik MünsterMünsterGermany
  2. 2.Institut für klinische RadiologieUniversität MünsterMünsterGermany

Personalised recommendations